Sector: Healthcare | Industry: Pharmaceuticals |
Company Contact | |
Address: | 333 Preston Street, Suite 710 OTTAWA ON K1S 5N4 |
Tel: | 1-416-8815154 |
Website: | https://indiva.ca |
IR: | See website |
Key People | ||
Carmine Edward Marotta Chief Executive Officer, Director | Jennifer Welsh Chief Financial Officer | Rob Carse Chief Operating Officer | Sung Kang Chief Commercial Officer |
Business Overview |
Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing the medical and recreational markets. The Company is engaged in producing and selling cannabis products, including dried flower, extract, and edible products. It focuses on the production and processing of edible and extract cannabis products as well as packaging of edibles and extracts. Its brands include Pearls by Gron, Bhang Chocolate, Indiva Doppio Sandwich Cookies, Indiva 1432 Chocolate, and No Future Gummies and Vapes, as well as other Indiva branded extracts. Its products include edibles and capsules. Its edibles include Vanilla Double -Stuffed Chocolate Cookie, Fudge Double-Stuffed Chocolate Cookie, and Golden Vanilla Double Stuffed Cookie. It sells its cannabis products to consumers in the recreational market in the provinces of Ontario, British Columbia, Alberta, Quebec, Nova Scotia, Saskatchewan, Manitoba, New Brunswick, Prince Edward Island, Newfound. |
Financial Overview |
For the nine months ended 30 September 2023, Indiva Ltd revenues increased 6% to C$26.7M. Net loss decreased 49% to C$4.1M. Revenues reflect licensed production and processing of cannabis. segment increase of 95% to C$17.3M. Lower net loss reflects Marketing and sales decrease of 21% to C$3.9M (expense), Share-based compensation decrease of 70% to C$129K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -C$0.06 to -C$0.03. |
Employees: | 142 as of Dec 31, 2020 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $31.93M as of Dec 31, 2023 |
Annual revenue (TTM): | $36.01M as of Dec 31, 2023 |
EBITDA (TTM): | -$3.87M as of Dec 31, 2023 |
Net annual income (TTM): | -$6.94M as of Dec 31, 2023 |
Free cash flow (TTM): | $0.13M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $17.98M as of Dec 31, 2023 |
Shares outstanding: | 195,488,563 as of Mar 13, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |